Free Newsletter
Pharma layoffs continue to roil U.K.
In Europe, pharma restructuring has hit the U.K. hardest, industry experts say, with British drugmakers cutting 11 percent to 15 percent of its jobs across the board over the past two years--and the cuts aren't over yet. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: